Advanced search
Publication Cover
OncoImmunology Volume 4, 2015 - Issue 8
Submit an article Journal homepage
824
Views
3
CrossRef citations to date
0
Altmetric
Author's View

Autocrine signaling of type 1 interferons in successful anticancer chemotherapy

Erika VacchelliGustave Roussy Cancer Campus; Villejuif, France;Université Paris XI, Faculté de Médecine; Le Kremlin Bicêtre, France;INSERM; U1138; Paris, France
,
Antonella SistiguGustave Roussy Cancer Campus; Villejuif, France;Université Paris XI, Faculté de Médecine; Le Kremlin Bicêtre, France;INSERM, U1015; Villejuif, France;Regina Elena National Cancer Institute; Rome, Italy
,
Takahiro YamazakiGustave Roussy Cancer Campus; Villejuif, France;Université Paris XI, Faculté de Médecine; Le Kremlin Bicêtre, France;INSERM, U1015; Villejuif, France
,
Ilio VitaleRegina Elena National Cancer Institute; Rome, Italy;University of Rome “Tor Vergata”, Department of Biology; Rome, Italy
,
Laurence ZitvogelGustave Roussy Cancer Campus; Villejuif, France;INSERM; U1138; Paris, France;INSERM, U1015; Villejuif, France;Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507; Villejuif, FranceCorrespondence[email protected] [email protected]
&
Guido KroemerGustave Roussy Cancer Campus; Villejuif, France;INSERM; U1138; Paris, France;Metabolomics Platform, Gustave Roussy Cancer Campus; Villejuif, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers; Paris, France;Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP; Paris, France;Université Paris Descartes, Sorbonne Paris Cité; Paris, France;Department of Biology and Pathology, Gustave Roussy Cancer Campus; Villejuif, FranceCorrespondence[email protected] [email protected]
Article: e988042 | Received 31 Oct 2014, Accepted 09 Nov 2014, Published online: 25 Jul 2015

References

  • Galluzzi L, Senovilla L, Zitvogel L, Kroemer G. The secret ally: immunostimulation by anticancer drugs. Nat Rev Drug Discov 2012; 11:215-33; PMID:22301798; http://dx.doi.org/10.1038/nrd3626
  • Zitvogel L, Galluzzi L, Smyth MJ, Kroemer G. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity 2013; 39:74-88; PMID:23890065; http://dx.doi.org/10.1016/j.immuni.2013.06.014
  • Kepp O, Senovilla L, Kroemer G. Immunogenic cell death inducers as anticancer agents. Oncotarget 2014; 5:5190-1; PMID:25114034
  • Antonopoulos C, Dubyak GR. Chemotherapy engages multiple pathways leading to IL-1beta production by myeloid leukocytes. Oncoimmunology 2014; 3:e27499; PMID:24800164; http://dx.doi.org/10.4161/onci.27499
  • Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol 2013; 31:51-72; PMID:23157435; http://dx.doi.org/10.1146/annurev-immunol-032712-100008
  • Michaud M, Sukkurwala AQ, Di Sano F, Zitvogel L, Kepp O, Kroemer G. Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress. Oncoimmunology 2014; 3:e28276; PMID:25050202; http://dx.doi.org/10.4161/onci.28276
  • Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot DP, Adam J, Vitale I, Goubar A, Baracco EE, Remédios C, et al. Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat Med 2014; 20:1301-9; PMID:25344738; http://dx.doi.org/10.1038/nm.3708
  • Ming Lim C, Stephenson R, Salazar AM, Ferris RL. TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR head and neck cancer cells. Oncoimmunology 2013; 2:e24677; PMID:23894722; http://dx.doi.org/10.4161/onci.24677
  • Ma Y, Mattarollo SR, Adjemian S, Yang H, Aymeric L, Hannani D, Portela Catani JP, Duret H, Teng MW, Kepp O, et al. CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy. Cancer Res 2014; 74:436-45; PMID:24302580; http://dx.doi.org/10.1158/0008-5472.CAN-13-1265
  • Stoll G, Enot D, Mlecnik B, Galon J, Zitvogel L, Kroemer G. Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy. Oncoimmunology 2014; 3:e27884; PMID:24790795; http://dx.doi.org/10.4161/onci.27884

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.